[What is new in pediatric rheumatological diseases?]

Manel Mejbri1, Aikaterini Koryllou2, Géraldine Blanchard-Rohner1

  • 1Unité d'immunologie-vaccinologie-rhumatologie pédiatrique, Service de pédiatrie générale, Département de la femme, de l'enfant et de l'adolescent, Hôpitaux universitaires de Genève, 1211 Genève 14.

Revue Medicale Suisse
|February 20, 2025
PubMed

Insights

Juvenile idiopathic arthritis (JIA) and systemic lupus erythematosus (SLE) are complex pediatric rheumatologic diseases. Advances in biotherapy and genetics offer more targeted treatments for JIA, SLE, vasculitis, and immune deficiencies.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Genetics

Context:

  • Juvenile idiopathic arthritis (JIA) and systemic lupus erythematosus (SLE) are complex pediatric rheumatologic conditions.
  • These diseases have significant genetic components and present diagnostic and therapeutic challenges.
  • Related conditions include pediatric systemic vasculitis and immune deficiencies linked to dysimmunity.

Purpose:

  • To explore various aspects of JIA and SLE.
  • To discuss pediatric systemic vasculitis and associated immune deficiencies.
  • To highlight recent advancements in understanding and treating these pediatric autoimmune and immune-related disorders.

Summary:

  • JIA and SLE are intricate pediatric autoimmune diseases with genetic underpinnings.
  • Biotherapy and genetic research have transformed treatment approaches.
  • The article reviews JIA, SLE, pediatric vasculitis, and immune deficiencies, emphasizing therapeutic progress.

Impact:

  • Provides an overview of complex pediatric rheumatologic and immune disorders.
  • Highlights the impact of genetic research and biotherapy on patient outcomes.
  • Informs clinicians and researchers about the latest developments in diagnosis and treatment for pediatric autoimmune diseases.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.1K